Research output

1. Corrigendum to “Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial” [Eur J Cancer. 227 (2025) 115674] (European Journal of Cancer (2025) 227, (S0959804925004563), (10.1016/j.ejca.2025.115674))

   Research output: Contribution to journal › Comment/debate › peer-review

2. 现阶段俄罗斯与欧盟经贸关系 的问题和前景 阿列克桑德拉·莫恰洛娃 谢尔盖·苏特林

   Research output: Contribution to journal › Article › peer-review

3. Фрагментация мировой экономики: факт реальности или очередной миф?

   Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

View all (3) »